3M Is Constrained by Sluggish End-Markets, but Product Innovations Could Help Reignite Growth
Estimating 3M's legal liabilities from producing per- and polyfluoroalkyl substances, or PFAS, is a highly uncertain exercise. While some believe these liabilities total greater than the firm's market capitalization, we think 3M's settlements and the spinoff of Solventum reduce 3M's risks substantially. We remain concerned over 3M's incremental PFAS-related liabilities, but we think they're manageable in their current state. 3M continues to work through PFAS-related claims in individual states in the US, with a handful resolved thus far and many more on the docket.